APA

Francia C. M., Marvaso G., Piperno G., Gandini S., Ferrari A., Zerella M. A., Arculeo S., Sibio D., Fodor C., Pepa M., Trivellato S., Rondi E., Vigorito S., Cattani F., Spaggiari L., De Marinis F., Orecchia R., Ciardo D. & Jereczek-Fossa B. A. (20200909). Lung optimized treatment with CyberKnife® in inoperable lung cancer patients: feasibility analysis of a mono-institutional 115 patient series. : Neoplasma.

Chicago

Francia C Maria, Marvaso G, Piperno G, Gandini S, Ferrari A, Zerella M Alessia, Arculeo S, Sibio D, Fodor C, Pepa M, Trivellato S, Rondi E, Vigorito S, Cattani F, Spaggiari L, De Marinis F, Orecchia R, Ciardo D and Jereczek-Fossa B Alicja. 20200909. Lung optimized treatment with CyberKnife® in inoperable lung cancer patients: feasibility analysis of a mono-institutional 115 patient series. : Neoplasma.

Harvard

Francia C. M., Marvaso G., Piperno G., Gandini S., Ferrari A., Zerella M. A., Arculeo S., Sibio D., Fodor C., Pepa M., Trivellato S., Rondi E., Vigorito S., Cattani F., Spaggiari L., De Marinis F., Orecchia R., Ciardo D. and Jereczek-Fossa B. A. (20200909). Lung optimized treatment with CyberKnife® in inoperable lung cancer patients: feasibility analysis of a mono-institutional 115 patient series. : Neoplasma.

MLA

Francia C Maria, Marvaso G, Piperno G, Gandini S, Ferrari A, Zerella M Alessia, Arculeo S, Sibio D, Fodor C, Pepa M, Trivellato S, Rondi E, Vigorito S, Cattani F, Spaggiari L, De Marinis F, Orecchia R, Ciardo D and Jereczek-Fossa B Alicja. Lung optimized treatment with CyberKnife® in inoperable lung cancer patients: feasibility analysis of a mono-institutional 115 patient series. : Neoplasma. 20200909.